E-LIB Suche - Ergebnisse für: Noriyoshi Iriyama

1

Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chro..:

Matsumura, Itaru ; Ohtake, Shigeki ; Atsuta, Yoshiko...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

2

RUNX1::RUNX1T1 Acute Myeloid Leukemia Cytogenetically Showi..:

Higuchi, Ai ; Iriyama, Noriyoshi
Cureus. , 2024

Link: https://doi.org/10.7759/..

3

Changes in chronic myeloid leukemia treatment modalities an..:

Iriyama, Noriyoshi ; Iwanaga, Eisaku ; Kimura, Yuta...
International Journal of Hematology. 120 (2024) 1 - p. 60-70 , 2024

Link: https://doi.org/10.1007/..

4

A Higher Neutrophil Count Is Associated with Favorable Achi..:

Ureshino, Hiroshi ; Takeda, Yusuke ; Kamachi, Kazuharu...
Clinics and Practice. 14 (2024) 4 - p. 1216-1224 , 2024

Link: https://doi.org/10.3390/..

5

An observational study of once-weekly carfilzomib in patien..:

Abe, Yu ; Kubonishi, Shiro ; Ri, Masaki...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

6

Management and Risk Factors for Pleural Effusion in Japanes..:

Tsuchiya, Shun ; Takaku, Tomoiku ; Watanabe, Naoki...
Internal Medicine. 62 (2023) 22 - p. 3299-3303 , 2023

Link: https://doi.org/10.2169/..

7

Clinical management of second-generation tyrosine kinase in..:

Tokuhira, Michihide ; Kimura, Yuta ; Tabayashi, Takayuki...
International Journal of Hematology. 118 (2023) 2 - p. 210-220 , 2023

Link: https://doi.org/10.1007/..

8

Importance of TKI treatment duration in treatment-free remi..:

Yoshida, Chikashi ; Yamaguchi, Hiroki ; Doki, Noriko...
International Journal of Hematology. 117 (2023) 5 - p. 694-705 , 2023

Link: https://doi.org/10.1007/..

9

PB2301: OPTIMAL DOSE INTENSITY OF R-CHOP FOR PATIENTS WITH ..:

Nukariya, Hironao ; Miura, Katsuhiro ; Takahashi, Hiromichi...
HemaSphere. 7 (2023) S3 - p. e46165d9 , 2023

Link: https://doi.org/10.1097/..

10

Pirarubicin‐based intensive chemotherapy followed by consol..:

Takahashi, Hiromichi ; Miura, Katsuhiro ; Nakagawa, Masaru...
Hematological Oncology. 40 (2022) 5 - p. 1094-1096 , 2022

Link: https://doi.org/10.1002/..

11

Chronic myeloid leukemia: the cutting-edge evidence and thi..:

Iriyama, Noriyoshi
International Journal of Hematology. 117 (2022) 1 - p. 1-2 , 2022

Link: https://doi.org/10.1007/..

12

von Willebrand factor activity levels are influenced by dri..:

Iizuka, Kazuhide ; Morishita, Soji ; Nishizaki, Yuji...
European Journal of Haematology. 109 (2022) 6 - p. 779-786 , 2022

Link: https://doi.org/10.1111/..

13

Outcomes of adolescents and young adults with chronic-phase..:

Nishiyama-Fujita, Yuriko ; Nakazato, Tomonori ; Iriyama, Noriyoshi...
Annals of Medicine. 54 (2022) 1 - p. 1244-1254 , 2022

Link: https://doi.org/10.1080/..

14

Clinical impact of central nervous system‐directed therapie..:

Takahashi, Hiromichi ; Nishimaki, Haruna ; Nakanishi, Yoko...
eJHaem. 3 (2022) 2 - p. 467-470 , 2022

Link: https://doi.org/10.1002/..

15

The EUTOS long‐term survival score predicts disease‐specifi..:

Sato, Eriko ; Iriyama, Noriyoshi ; Tokuhira, Michihide...
Cancer Medicine. 9 (2020) 23 - p. 8931-8939 , 2020

Link: https://doi.org/10.1002/..